Behrooz Johari

13PUBLICATIONS
17CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsMedical infection agents (incl. prions)NanomaterialsNanomedicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jan 17, 2022
Anticancer evaluation of methotrexate and curcumin-coencapsulated niosomes against colorectal cancer cell lines.

Navid Mousazadeh, Mahmoud Gharbavi, Hamid Rashidzadeh

|Dec 30, 2020
Application of decoy oligodeoxynucleotides strategy for inhibition of cell growth and reduction of metastatic properties in nonresistant and erlotinib-resistant SW480 cell line.

Zoleykha Asadi, Mojtaba Fathi, Elham Rismani

|Dec 30, 2020
Investigating the anti-inflammatory effects of high molecular weight secretions from Limosilactobacillus reuteri PTCC 1655 on LPS-stimulated PMA-differentiated THP-1 cells.

B Johari, F Maghsood, H Madanchi

|Dec 07, 2020
NANOG Decoy Oligodeoxynucleotide-Encapsulated Niosomes Nanocarriers: A Promising Approach to Suppress the Metastatic Properties of U87 Human Glioblastoma Multiforme Cells.

Mahmoud Gharbavi, Behrooz Johari, Elham Rismani

|Aug 26, 2020
Evaluation of STAT3 decoy oligodeoxynucleotides' synergistic effects on radiation and/or chemotherapy in metastatic breast cancer cell line.

Behrooz Johari, Mohammad Rahmati, Leila Nasehi

|Aug 26, 2020
Cholesterol-conjugated bovine serum albumin nanoparticles as a tamoxifen tumor-targeted delivery system.

Mahmoud Gharbavi, Behrooz Johari, Seyed Sadegh Eslami

Pageof 3

Frequent Collaborators

3 joint publications

Mehdi Kadivar

2 joint publications

Mahmoud Gharbavi

1 joint publications

M Moradi

1 joint publications

Leila Saremi